Altered peptide ligands narrow the repertoire of cellular immune responses by interfering with T-cell priming
暂无分享,去创建一个
[1] R. Sinden,et al. Protection from Plasmodium berghei infection by priming and boosting T cells to a single class I‐restricted epitope with recombinant carriers suitable for human use , 1998, European journal of immunology.
[2] Marion Becker,et al. Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara , 1998, Nature Medicine.
[3] P. Allen,et al. Inhibition of an in vitro CD4+ T cell alloresponse using altered peptide ligands. , 1998, Journal of immunology.
[4] D. Kwiatkowski,et al. Association of malaria parasite population structure, HLA, and immunological antagonism. , 1998, Science.
[5] A. Hill,et al. A protein particle vaccine containing multiple malaria epitopes , 1997, Nature Biotechnology.
[6] H. Yagita,et al. Impaired induction of cytotoxic T lymphocytes by antagonism of a weak agonist borne by a variant hepatitis C virus epitope , 1997, European journal of immunology.
[7] A. Hill,et al. Precursor frequency analysis of cytotoxic T lymphocytes to pre-erythrocytic antigens of Plasmodium falciparum in West Africa. , 1997, Journal of immunology.
[8] Partho Ghosh,et al. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2 , 1996, Nature.
[9] V. Apostolopoulos,et al. Cell-mediated immune responses to MUC1 fusion protein coupled to mannan. , 1996, Vaccine.
[10] M. Nowak,et al. Population Dynamics of Immune Responses to Persistent Viruses , 1996, Science.
[11] P. Allen,et al. Endogenous altered peptide ligands can affect peripheral T cell responses , 1996, The Journal of experimental medicine.
[12] S. Hoffman,et al. Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity , 1996, The Journal of experimental medicine.
[13] D I Stuart,et al. An altered position of the alpha 2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501. , 1996, Immunity.
[14] A. Sette,et al. Major histocompatibility complex binding affinity of an antigenic determinant is crucial for the differential secretion of interleukin 4/5 or interferon gamma by T cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[15] Sunetra Gupta,et al. Dynamic interactions in malaria: host heterogeneity meets parasite polymorphism , 1995, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[16] M. Davenport,et al. Antagonists or altruists: do viral mutants modulate T-cell responses? , 1995, Immunology today.
[17] P. Klenerman,et al. The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus , 1995, European journal of immunology.
[18] H. Grey,et al. MHC blocking peptides and T-cell receptor antagonists: novel paths to selective immunosuppression? , 1995, Chemical immunology.
[19] Martin A. Nowak,et al. Antigenic oscillations and shifting immunodominance in HIV-1 infections , 1995, Nature.
[20] M. Aidoo,et al. Induction of peptide‐specific primary cytotoxic T lymphocyte responses from human peripheral blood , 1995, European journal of immunology.
[21] A. Sette,et al. Differential activation of proliferation and cytotoxicity in human T-cell lymphotropic virus type I Tax-specific CD8 T cells by an altered peptide ligand. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[22] A. Hill,et al. Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria , 1995, The Lancet.
[23] A. Sette,et al. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo , 1995, The Journal of experimental medicine.
[24] A. Sette,et al. Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. , 1995, Immunity.
[25] D. Mitchell,et al. Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon gamma and tumor necrosis factor alpha production , 1994, The Journal of experimental medicine.
[26] J. Levy,et al. Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein , 1994, The Journal of experimental medicine.
[27] A. Sette,et al. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells , 1994, Nature.
[28] Sarah Rowland-Jones,et al. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants , 1994, Nature.
[29] H. Grey,et al. Negative selection of CD4+ CD8+ thymocytes by T-cell receptor peptide antagonists. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[30] M. Bevan,et al. Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells , 1993, The Journal of experimental medicine.
[31] P. Allen,et al. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells , 1993, Nature.
[32] J. Bell,et al. Characterization of the human T cell receptor α‐chain repertoire and demonstration of a genetic influence on Vα usage , 1993, European journal of immunology.
[33] P. Allen,et al. Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides. , 1993, Journal of immunology.
[34] M. Aidoo,et al. Molecular analysis of the association of HLA-B53 and resistance to severe malaria , 1992, Nature.
[35] Charles R. M. Bangham,et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition , 1991, Nature.
[36] P. Allen,et al. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. , 1991, Science.
[37] V. Nussenzweig,et al. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria , 1989, Nature.
[38] S. Hoffman,et al. Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes. , 1989, Science.
[39] J. Rothbard,et al. Enhanced recognition of a modified peptide antigen by cytotoxic T cells specific for influenza nucleoprotein , 1988, Cell.
[40] T. Espevik,et al. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. , 1986, Journal of immunological methods.
[41] J Alexander,et al. Antigen analogs/MHC complexes as specific T cell receptor antagonists. , 1994, Annual review of immunology.
[42] E. Nardin,et al. T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages. , 1993, Annual review of immunology.